参考文献/References:
[1] UCHINO M,YOKOI N,UCHINO Y,DOGRU M,KAWASHIMA M,KOMURO A,et al.Prevalence of dry eye disease and its risk factors in visual display terminal users: the Osaka study[J].Am J Ophthalmol,2013,156(4):759-766.
[2] CRAIG J P,NICHOLS K K,NICHOLS J J,CAFFERY B,STAPLETON F.TFOS DEWS II definition and classification report[J].Ocul Surf,2017,15(3):276-283.
[3] GIANNACCARE G,PELLEGRINI M,SEBASTIANI S,BERNABEI F,CAMPOS EMILIO C.Efficacy of omega-3 fatty acid supplementation for treatment of dry eye disease: a meta-analysis of randomized clinical trials[J].Cornea,2019,38(5):565-573.
[4] TOYOS R,MCGILL W,BRISCOE D.Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction: a 3-year retrospective study[J].Photomed Laser Surg,2015,33(1):41-46.
[5] 戴鹏飞,李颖,田芳,王玉倩,倪珊珊,王洁.强脉冲光联合睑板腺按摩与眼睑熏蒸按摩治疗MGD相关干眼的疗效对比[J].国际眼科杂志,2019,19(12):2101-2106.
DAI P F,LI Y,TIAN F,WANG Y Q,NI S S,WANG J.Efficacy comparison of intense pulsed light combined with meibomian gland massage and eyelid fumigation massage in the treatment of MGD-related dry eyes[J].Int Eye Sci,2019,19(12):2101-2106.
[6] ZUAZO F,LPEZ-PONCE D,SALINAS-TORO D,VALENZUELA F,SANS-PUROJA J,SRUR M,et al.Conjunctival impression cytology in patients with normal and impaired OSDI scores[J].Arch Soc Esp Oftalmol,2014,89(10):391-396.
[7] 洪晶.我国睑板腺功能障碍诊断与治疗专家共识(2017年)[J].中华眼科杂志,2017,53(9):657-661.
HONG J.Diagnosis and treatment of Meibomian gland dysfunction in China(2017)[J].Chin J Ophthalmol,2017,53(9):657-661.
[8] AMPARO F,WANG H,YIN J,MARMALIDOU A,DANA R.Evaluating corneal fluorescein staining using a novel automated method[J].Invest Ophthalmol Vis Sci,2017,58(6):168-173.
[9] BERTA A,TOTH-MOLNAR E,CSUTAK A.New international consensus statement about the definition,classification,ethiology,diagnostics and therapy of dry eye (TFOS DEWS II)[J].Orv Hetil,2018,159(20):775-785.
[10] PAPAGEORGIOU P,CLAYTON W,NORWOOD S,CHOPRA S,RUSTIN M.Treatment of rosacea with intense pulsed light: significant improvement and long-lasting results [J].Br J Dermatol,2008,159(3):628-632.
[11] FARIVAR S,MALEKSHAHABI T,SHIARI R.Biological effects of low level laser therapy[J].J Lasers Med Sci,2014,5(2):58-62.
[12] LIU R,BEI R,PING T,TANG Y,SONG W.Analysis of cytokine levels in tears and clinical correlations after intense pulsed light treating Meibomian gland dysfunction[J].Am J Ophthalmol,2017,183:81-90.
[13] MEJA L F,GIL J,JARAMILLO M.Intense pulsed light therapy: a promising complementary treatment for dry eye disease[J].Arch Soc Esp Oftalmol,2019,94:331-336.
[14] LI D,LIN S B,CHENG B.Intense pulsed light treatment for meibomian gland dysfunction in skin types III/IV[J].Photobiomodul Photomed Laser Surg,2019,37(2):70-76.
[15] YIN Y,LIU N,GONG L,SONG N.Changes in the meibomian gland after exposure to intense pulsed light in meibomian gland dysfunction (MGD) patients[J].Curr Eye Res,2018,43(3):308-313.
[16] JIANG X,LV H,HANG S,ZHANG M,LIU Y.Evaluation of the safety and effectiveness of intense pulsed light in the treatment of meibomian gland dysfunction [J].J Ophthalmol,2016,2016:1910694.
[17] CABALLERO S G,MADRONA J,REINA E C.Effect of pulsed laser light in patients with dry eye syndrome[J].Arch Soc Esp Oftalmol,2017,92(11):509-515.
[18] QIU J J,SUN T,FU S H,YU Y F,YOU Z P,ZHANG Q,et al.A study of dry eye after cataract surgery in MGD patients[J].Int Ophthalmol,2020,40(5):1277-1284.
相似文献/References:
[1]皮百木 穆红梅 张婉婷 郑娜 李娟.老年干眼患者眼表改变及其与睑板腺功能障碍的相关性[J].眼科新进展,2013,33(6):000.
[2]谭业双 周霞 许 玲 王玲丽 樊玲.抗炎治疗睑板腺功能障碍的临床研究[J].眼科新进展,2012,32(1):000.
[3]杨帆,曾庆延.睑板腺功能障碍治疗进展[J].眼科新进展,2016,36(10):996.[doi:10.13389/j.cnki.rao.2016.0267]
YANG Fan,ZENG Qing-Yan.Research progress on treatment of meibomian gland dysfunction[J].Recent Advances in Ophthalmology,2016,36(12):996.[doi:10.13389/j.cnki.rao.2016.0267]
[4]李妍,桑璇,王晓然,等.干眼患者泪膜脂质层厚度检测及其与眼表体征的相关性分析[J].眼科新进展,2017,37(4):344.[doi:10.13389/j.cnki.rao.2017.0087]
LI Yan,SANG Xuan,WANG Xiao-Ran,et al.Measurement of tear film lipid layer thickness in dry eye patients and its relationship with ocular surface signs[J].Recent Advances in Ophthalmology,2017,37(12):344.[doi:10.13389/j.cnki.rao.2017.0087]
[5]余婷,叶芬,施宇华,等.睑板腺功能障碍患者的视觉质量分析[J].眼科新进展,2017,37(10):966.[doi:10.13389/j.cnki.rao.2017.0245]
YU Ting,YE Fen,SHI Yu-Hua,et al.Evaluation of visual quality in patients with meibomian gland dysfunction[J].Recent Advances in Ophthalmology,2017,37(12):966.[doi:10.13389/j.cnki.rao.2017.0245]
[6]袁媛.干眼危险因素的研究[J].眼科新进展,2017,37(12):1173.[doi:10.13389/j.cnki.rao.2017.0296]
YUAN Yuan.Risk factors for dry eye[J].Recent Advances in Ophthalmology,2017,37(12):1173.[doi:10.13389/j.cnki.rao.2017.0296]
[7]石文卿,孙铁,朱佩文,等.老年性睑板腺功能障碍患者下睑内翻的两种术式疗效对比[J].眼科新进展,2018,38(11):1041.[doi:10.13389/j.cnki.rao.2018.0245]
SHI Wen-Qing,SUN Tie,ZHU Pei-Wen,et al.Analysis of the effect of two surgical correction methods for lower eyelid entropion in patients with meibomian gland dysfunction[J].Recent Advances in Ophthalmology,2018,38(12):1041.[doi:10.13389/j.cnki.rao.2018.0245]
[8]熊超,赖瑶,艾丽珍,等.红外线照相技术联合活体共聚焦显微镜对轻度睑板腺功能障碍患者早期诊断价值的研究[J].眼科新进展,2021,41(1):069.[doi:10.13389/j.cnki.rao.2021.0015]
XIONG Chao,LAI Yao,AI Lizhen,et al.The value of infrared photography combined with in vivo confocal microscopy in the early diagnosis of patients with mild meibomian gland dysfunction[J].Recent Advances in Ophthalmology,2021,41(12):069.[doi:10.13389/j.cnki.rao.2021.0015]
[9]王蓉,邓应平.水液缺乏型干眼和混合型干眼患者睑板腺形态及功能差异[J].眼科新进展,2021,41(8):783.[doi:10.13389/j.cnki.rao.2021.0163]
WANG Rong,DENG Yingping.Morphologic and functional differences of meibomian gland in patients with aqueous-deficient dry eyes and mixed dry eyes[J].Recent Advances in Ophthalmology,2021,41(12):783.[doi:10.13389/j.cnki.rao.2021.0163]
[10]曹宇辰,张杰鑫,黎颖莉,等.有无睑板腺功能障碍患者眼表菌群组成对比[J].眼科新进展,2021,41(12):1138.[doi:10.13389/j.cnki.rao.2021.0238]
CAO Yuchen,ZHANG Jiexin,LI Yingli,et al.Comparison of ocular surface microbial colonies between patients with and without meibomian gland dysfunction[J].Recent Advances in Ophthalmology,2021,41(12):1138.[doi:10.13389/j.cnki.rao.2021.0238]